Choroidal evaluation in patients under alpha-lytic therapy.
Maddalena De Bernardo1, Vincenzo Altieri2, Alessia Coppola2
1Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, via S. Allende, 84081, Baronissi, Salerno, Italy. mdebernardo@unisa.it.
Summary
Alpha-lytic drug withdrawal led to a significant reduction in choroidal thickness (CT). This CT decrease may serve as a key indicator for optimizing cataract surgery timing.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Ocular Imaging
Background:
- Alpha-lytic drugs are commonly used, potentially affecting ocular structures.
- Cataract surgery timing is crucial for optimal visual outcomes.
- Choroidal thickness (CT) changes may provide insights into ocular health relevant to surgery.
Purpose of the Study:
- To evaluate choroidal thickness (CT) changes following alpha-lytic drug withdrawal.
- To determine if CT changes can aid in cataract surgery timing decisions.
Main Methods:
- Observational, prospective study of 25 patients undergoing cataract surgery after alpha-lytic therapy.
- Comparison with 25 control subjects without alpha-lytic therapy.
- High-resolution spectral domain optical coherence tomography (EDI-OCT) to measure CT before and after drug withdrawal.
Main Results:
- A statistically significant reduction in subfoveal and peripheral CT was observed after alpha-lytic drug withdrawal (p < 0.05).
- No significant CT changes were noted in the control group (p > 0.05).
- No cases of severe floppy iris syndrome were reported.
Conclusions:
- CT decrease after alpha-lytic drug withdrawal is a significant finding.
- Monitoring CT changes could be a valuable tool for guiding cataract surgery timing.
More Related Videos
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
864
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
864
01:28Angle Closure Glaucoma: Treatment
997
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
997
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K